Patent attorney KIM & CHANG Seoul National University, B.S. Lim Jaeyoung / Intellectual Property I worked as a patent attorney in Kim&Chang law firm after graduating School of Chemical and Biological Engineering in Seoul National University. Currently, I am leading Intellectual Property team at Voronoi. "I had been leading many cases on patent and intellectual property on behalf of global leading companies including pharmaceutical companies. Especially, I was handling many IP M&A cases including IP due diligence and freedom-to-operate analysis. Also I worked at JunHe, the Chinese law firm, and handled many cases on China IP issue. Based on this experience, I am currently leading IP team and building IP strategy in Voronoi to protect our valuable assets in pipeline and maximize the value of them. The importance of intellectual property in pharmaceutical and biology area is never too high. In order to protect and increase the value of assets in pipeline, protecting IP rights and designing IP strategies is essential. I will do my best to maximize Voronoi’s pipeline values through IP management." Patent attorney KIM & CHANG Seoul National University, B.S. Lim Jaeyoung / Intellectual Property I worked as a patent attorney in Kim&Chang law firm after graduating School of Chemical and Biological Engineering in Seoul National University. Currently, I am leading Intellectual Property team at Voronoi. "I had been leading many cases on patent and intellectual property on behalf of global leading companies including pharmaceutical companies. Especially, I was handling many IP M&A cases including IP due diligence and freedom-to-operate analysis. Also I worked at JunHe, the Chinese law firm, and handled many cases on China IP issue. Based on this experience, I am currently leading IP team and building IP strategy in Voronoi to protect our valuable assets in pipeline and maximize the value of them. The importance of intellectual property in pharmaceutical and biology area is never too high. In order to protect and increase the value of assets in pipeline, protecting IP rights and designing IP strategies is essential. I will do my best to maximize Voronoi’s pipeline values through IP management."

(前) DB자산운용, 퀀트운용 서울대학교 수리과학부, 학사 Lee Kyungho /AI and Applied Mathematics We aim to develop platform for new drug development through applying machine learning technology. "Machine learning is applied to a variety of areas such as image recognition, voice regonition, autonomous driving, etc. Recently, it is being applied to life sciences as well and prediction in protein folding which shows better performance than existing method is one of the representative cases. AI Lab aims to develop machine learning model that is specifically designed for new drug development. We are continuing our research and development in creating the effective solution to all possible problems in the journey of new drug development. There is not much data accumulated in this field and therefore, it is critical to effectively and efficiently analyze and use the data and knowledge we have in hand. We are using unsupervised learning method and with more data to come from Voronoi scientists and R&D team, we expect to improve our AI development platform. I had been working at finance industry, specifically focusing on quantitative investing for the last 10 years. Currently, I am applying my experience to new drug development in Voronoi AI lab." (前) DB자산운용, 퀀트운용 서울대학교 수리과학부, 학사 Lee Kyungho /AI and Applied Mathematics We aim to develop platform for new drug development through applying machine learning technology. "Machine learning is applied to a variety of areas such as image recognition, voice regonition, autonomous driving, etc. Recently, it is being applied to life sciences as well and prediction in protein folding which shows better performance than existing method is one of the representative cases. AI Lab aims to develop machine learning model that is specifically designed for new drug development. We are continuing our research and development in creating the effective solution to all possible problems in the journey of new drug development. There is not much data accumulated in this field and therefore, it is critical to effectively and efficiently analyze and use the data and knowledge we have in hand. We are using unsupervised learning method and with more data to come from Voronoi scientists and R&D team, we expect to improve our AI development platform. I had been working at finance industry, specifically focusing on quantitative investing for the last 10 years. Currently, I am applying my experience to new drug development in Voronoi AI lab."